Complex regulatory, litigation, and business environments can threaten every phase of life sciences ventures. At Robins Kaplan LLP, our life sciences attorneys know the industry’s unique demands and help both proven and emerging industry clients establish, protect, and defend their most important innovations and advancements. Our life sciences attorneys and scientists hold advanced degrees in areas such as biology, chemistry, biochemistry, biomedical engineering, pharmacology, and physics. This background--along with industry-specific advanced strategies earned while litigating patent infringement, trade secret, and other life sciences IP disputes— enables us to counsel clients and drive results both in an out of the courtroom. In that regard, our life sciences attorneys have in-depth knowledge of the regulatory scheme and issues surrounding the Biologics Price Competition and Innovation Act (BPCIA). Our attorneys have litigation experience with follow-on biologics, and we provide opinions and conduct due diligence on behalf of clients looking to enter the biosimilars market. We also partner with clients to develop innovative pricing models to keep inventions moving forward.
Our capabilities have resulted in litigation and monetization successes in technologies as diverse as pharmaceutical formulations and active drug compounds, polymers, biofuels, MRI and catheter technologies, erythropoietin products, protein production from host cells, recombinant DNA technology, human growth hormone, and transgenic mice.